If it weren’t for his promising but ultimately limited running skills, which attracted considerable attention when he was in high school in China, Kehan Ren m ...
Real-time ctDNA MRD testing guides early chemo de-escalation in diffuse large B-cell lymphoma, aiming to cut toxicity without losing cure rates. In an interview with Targeted Oncology, Hua-Jay “Jeff” ...
Hematology-oncology physicians who treat sickle cell disease (SCD) have higher rates of burnout than non-SCD-focused physicians, according to a study published online March 11 in Blood Advances.
Circulating tumor DNA levels a few weeks after immunotherapy initiation could help identify patients with melanoma at greatest risk for recurrence or death.A retrospective analysis showed individuals ...
Hematology-oncology trained physicians who treat sickle cell disease reported higher rates of burnout (60%) than their counterparts who do not provide sickle cell care (43%) despite no differences in ...
Hematology-oncology-trained physicians who treat sickle cell disease reported higher rates of burnout (60%) than their counterparts who do not provide sickle cell care (43%) despite no differences in ...
A narrative review examines how generative AI tools such as large language models and vision-language models could assist precision oncology by interpreting genomic data, matching patients to clinical ...
Dr. Will Parsons, of Texas Children’s, discusses evolving therapies, survivorship clinics and tools like Passport For Care for long-term cancer care. For a child diagnosed with cancer, cure is the ...
HemOnc Today is excited to announce the nominees for its annual Disruptive Innovators Awards in hematology and oncology.Individuals who changed the face of the specialty and pushed the status quo ...
Retrospective cohorts show GLP-1 RA exposure yields ~5% relative weight reduction and an apparent OS advantage, while ...
As previously presented, gedatolisib + palbociclib + fulvestrant (“gedatolisib triplet”) and gedatolisib + fulvestrant (“gedatolisib doublet”) ...
What should oncology nurses and advanced practice providers understand about GLP-1 RAs in the care of patients with breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results